This HTML5 document contains 137 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://dx.doi.org/10.1111/
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q39697622
rdf:type
wikibase:Item
schema:description
2004 nî lūn-bûn مقالة علمية articol științific 2004年学术文章 2004年學術文章 scientific article мақолаи илмӣ scienca artikolo научная статья наукова стаття, опублікована в листопаді 2004 مقالهٔ علمی บทความทางวิทยาศาสตร์ 2004年學術文章 artigo científico vědecký článek επιστημονικό άρθρο 2004年學術文章 wissenschaftlicher Artikel 2004年の論文 artikull shkencor artykuł naukowy mokslinis straipsnis научни чланак 2004年学术文章 bài báo khoa học научни чланак videnskabelig artikel (udgivet 2004) 2004年学术文章 vitenskapelig artikkel articolo scientifico article científic naučni članak სამეცნიერო სტატია artigo científico (publicado na 2004) 2004년 논문 artículu científicu espublizáu en 2004 мақолаи илмӣ tieteellinen artikkeli teaduslik artikkel article scientifique (publié 2004) wetenschappelijk artikel artigo científico (publicado na 2004) article scientific 2004年學術文章 artículo científico publicado en 2004 vedecký článok 2004年学术文章 artikulong pang-agham vitskapeleg artikkel 2004年學術文章 bilimsel makale научна статия 2004年学术文章 vetenskaplig artikel ২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ tudományos cikk سائنسی مضمون מאמר מדעי 2004年學術文章 գիտական հոդված
p:P577
wds:Q39697622-D6B63AEF-2FBE-4EB3-9556-10944CE44031
wdt:P577
2004-11-01T00:00:00Z
p:P2860
wds:Q39697622-0599D64C-C546-4487-88CC-8F9E4C49F052 wds:Q39697622-1F89A28C-D0FD-48F2-B589-31C5C404A863 wds:Q39697622-30905E38-C711-429E-8D3D-55D199AB7CF7 wds:Q39697622-450E765A-5917-4FCF-9263-093763F9F8DF wds:Q39697622-64CA0A99-4E00-4D8B-A2AC-138BC4C21D72 wds:Q39697622-7D56D45D-960F-45FF-ABC7-EC6A50A3553A wds:Q39697622-9003C817-785A-4BB7-96F7-588F0D7450C2 wds:Q39697622-9FFD44D6-DAA7-4B27-9853-EA1474C36E9E wds:Q39697622-A3CE3D2E-E998-4F54-B9D5-70BCF35231B7 wds:Q39697622-ACDAD222-48B1-443A-953B-A0D67CE063A0 wds:Q39697622-B9EEAC03-6B5F-476C-BF72-2128A7C7D82A wds:Q39697622-E30BA187-5682-4D21-8F51-8ACF46E04EA7 wds:Q39697622-E7B7B712-B9BC-491E-9026-B71B9F63AA87 wds:Q39697622-E8698323-8D8E-4DB6-A9BE-C6B436651A33 wds:Q39697622-EE2A2EA3-C52A-44F9-B813-6DF2FDA9B181 wds:Q39697622-EF204EBB-76AD-417D-B00D-B2F8148932DA wds:Q39697622-F36746CF-7DFC-4C1B-A033-CA60FBABCCB9
wdt:P2860
wd:Q35803071 wd:Q33864006 wd:Q28287165 wd:Q34191226 wd:Q34278778 wd:Q40578914 wd:Q33544360 wd:Q34237411 wd:Q42557234 wd:Q33963983 wd:Q28174646 wd:Q44111689 wd:Q34708763 wd:Q34775765 wd:Q34450874 wd:Q45306489 wd:Q53523276
p:P2093
wds:Q39697622-CC4A25B0-7D93-4D0A-832D-D0F69D021856 wds:Q39697622-C4174253-6D91-41C2-8314-5F41B4E3B52A wds:Q39697622-0E1B1E94-DAEB-4F2C-BF83-F30BEAC727AF wds:Q39697622-683EE179-FA61-4BD6-B5FF-79B09B1E7E39 wds:Q39697622-72FD4144-CD40-4291-9651-931D7F5B8A37 wds:Q39697622-4396E581-7B1F-4712-A8A7-B0F3025BA093 wds:Q39697622-76521AA3-59D6-4CC8-8285-870E505F26D9
wdt:P2093
Tsuguya Fukui Andrew C Seger Joseph W So Julie M Fiskio Tejal K Gandhi Takeshi Morimoto E Francis Cook
rdfs:label
An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors
skos:prefLabel
An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors
schema:name
An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors
p:P50
wds:Q39697622-BF3688BE-EEAF-40D4-B48C-5CF358DA5FD6
wdt:P50
wd:Q17505360
p:P1476
wds:Q39697622-3E092CA0-40F4-4F3C-B9D7-2C67C354F678
wdt:P1476
An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors
p:P304
wds:Q39697622-617FC0F3-6BF5-4A87-93F6-50F057CB3188
wdt:P304
499-509
p:P31
wds:Q39697622-FDCF3B1C-2C39-482A-84AD-CFE74B9919A3
wdt:P31
wd:Q13442814
p:P698
wds:Q39697622-27832C6A-EB3A-4DA0-9092-DB428CBC3EDE
wdtn:P698
n10:15482412
wdt:P698
15482412
p:P1433
wds:Q39697622-C87755D4-EE8D-40CD-9F45-D6B2D864D199
wdt:P1433
wd:Q15767649
p:P433
wds:Q39697622-8EE83170-C2D7-45CA-A38B-7E7277808316
p:P478
wds:Q39697622-490C97F3-F817-4192-B07A-828146DC6462
wdt:P433
4
wdt:P478
10
p:P356
wds:Q39697622-37A51185-4553-4561-AB9C-2D74317880CC
wdtn:P356
n11:J.1365-2753.2003.00484.X
wdt:P356
10.1111/J.1365-2753.2003.00484.X